Shao-Lee Lin, Acelyrin CEO
Acelyrin files to go public in rare sign of biotech IPO
California biotech Acelyrin has filed to go public, a rare attempt to access the stock markets after a year of stock …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
